| Pharmaceutical active ingredients: |
| Clonidine |
| Available forms, composition and doses of Catapres-TTS: |
| Film, Extended Release; Transdermal; Clonidine 0.1 mg / 24 hFilm, Extended Release; Transdermal; Clonidine 0.2 mg / 24 hFilm, Extended Release; Transdermal; Clonidine 0.3 mg / 24 h |
| Catapres-TTS medical category: |
| Human:AntihypertensivesCentral alpha-agonists |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C02AC01 - Clonidine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Boehringer Ingelheim |
| Related documents and information about Catapres-TTS: |
| Catapres prescribing information (PDF)Catapres-TTS prescribing information (PDF) |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Cataplasme Sinapise Defresne | Linseed Flour; Mustard Flour de-oiled | Chefaro-Ardeval Laboratoires |
| Catapres | Clonidine Hydrochloride | Boehringer Ingelheim; German Remedies; Metro Drug Distribution; Zydus Cadila |
| Catapres Diu | Chlorthalidone; Clonidine Hydrochloride | Boehringer Ingelheim; German Remedies; Zydus Cadila |
| Catapresan | Clonidine | Boehringer Ingelheim |
| Catapressan | Clonidine | Boehringer Ingelheim |
| Catarase | Chymotrypsin | Novartis; Iolab Pharmaceuticals |
| Cataren | Diclofenac Potassium | Instituto Nacional de Quimioterapia |
| Catarest | Calcium Chloride; Potassium Iodide; Sodium Chloride | Centaur Laboratories |
| Cataridol | Calcium Chloride; Magnesium Chloride; Sodium Chloride | Novartis |
| Catarluse sans Thyroide | Calcium Gluconate; Ferrous Glycerophosphate; Magnesium Glycerophosphate; Manganese Nucleinate; Parathyroid Powdered; Testicles Powdered; Vitamin D2 (Ergocalciferol) | Abbott |